Table 3.
Discrepancies between BCID2 and conventional culture and phenotypic antimicrobial susceptibility test results.
| Patient | BCID2 Result | Conventional Culture and Phenotypic Susceptibility Testing Result(s) |
|---|---|---|
| Polymicrobial cultures | ||
| Patient #3 | Klebsiella pneumoniae, Acinetobacter calcoaceticus-baumannii complex, E. coli, Streptococcus spp. | Klebsiella pneumoniae |
| Patient #11 | Staphylococcus epidermidis (gen mec A/C), Streptococcus spp. | Methicillin-resistant Staphylococcus epidermidis |
| Patient #31 | E. coli/Klebsiella pneumoniae (CTX-M), Proteus spp., Serratia marcescens | ESBL-producing E. coli, Serratia marcescens |
| Discrepancies between resistance genes identified by BCID2 panel and phenotypic antimicrobial susceptibility test results | ||
| Patient #4 | Klebsiella oxytoca | ESBL-producing Klebsiella oxytoca |
| Patient # 25 | Staphylococcus epidermidis | Methicillin-resistant Staphylococcus epidermidis |
| Discrepancy in organism identification | ||
| Patient #10 | Non-identified | Acinetobacter lwoffii |
| Patient #15 | Non-identified | Pseudomonas putida |
| Patient #27 | Staphylococcus epidermidis (gen mec A/C) | Candida kefyr |
Abbreviations: BCID2= Blood Culture Identification 2 (BCID2) Panel, ESBL= Extended-spectrum beta-lactamase.